MONTECUCCO, CARLOMAURIZIO
 Distribuzione geografica
Continente #
NA - Nord America 22.899
AS - Asia 18.616
EU - Europa 13.728
SA - Sud America 2.528
AF - Africa 643
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 15
Totale 58.461
Nazione #
US - Stati Uniti d'America 22.398
CN - Cina 8.828
SG - Singapore 4.194
IE - Irlanda 3.262
HK - Hong Kong 2.040
BR - Brasile 1.895
VN - Vietnam 1.755
DE - Germania 1.744
UA - Ucraina 1.711
RU - Federazione Russa 1.575
FI - Finlandia 1.483
FR - Francia 886
SE - Svezia 865
IT - Italia 835
GB - Regno Unito 668
IN - India 404
ZA - Sudafrica 337
CA - Canada 275
AR - Argentina 233
BD - Bangladesh 228
IQ - Iraq 156
JP - Giappone 149
MX - Messico 122
TR - Turchia 122
AT - Austria 106
EC - Ecuador 103
CO - Colombia 95
PK - Pakistan 91
NL - Olanda 90
PL - Polonia 89
ES - Italia 85
SA - Arabia Saudita 79
ID - Indonesia 73
BE - Belgio 68
VE - Venezuela 62
MA - Marocco 58
UZ - Uzbekistan 54
PH - Filippine 51
CZ - Repubblica Ceca 49
TN - Tunisia 44
AE - Emirati Arabi Uniti 42
MY - Malesia 42
IR - Iran 41
CL - Cile 39
KE - Kenya 39
EG - Egitto 38
LT - Lituania 35
PY - Paraguay 34
NP - Nepal 29
JO - Giordania 28
PE - Perù 27
AU - Australia 25
IL - Israele 25
ET - Etiopia 23
AZ - Azerbaigian 21
KZ - Kazakistan 21
RO - Romania 21
DZ - Algeria 20
SN - Senegal 20
CR - Costa Rica 19
MU - Mauritius 19
AL - Albania 18
DO - Repubblica Dominicana 18
UY - Uruguay 18
BO - Bolivia 17
OM - Oman 16
PA - Panama 14
TH - Thailandia 14
LV - Lettonia 13
DK - Danimarca 12
HU - Ungheria 12
KG - Kirghizistan 12
PS - Palestinian Territory 12
KR - Corea 11
LB - Libano 11
SY - Repubblica araba siriana 11
BG - Bulgaria 10
EU - Europa 10
HN - Honduras 10
RS - Serbia 10
GR - Grecia 9
NI - Nicaragua 9
SK - Slovacchia (Repubblica Slovacca) 9
TT - Trinidad e Tobago 9
BY - Bielorussia 8
KW - Kuwait 8
MK - Macedonia 8
NG - Nigeria 8
PT - Portogallo 8
CH - Svizzera 7
GE - Georgia 7
HR - Croazia 7
JM - Giamaica 7
LK - Sri Lanka 7
MD - Moldavia 7
NO - Norvegia 5
NZ - Nuova Zelanda 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AO - Angola 4
BA - Bosnia-Erzegovina 4
Totale 58.359
Città #
Dublin 3.241
Chandler 3.007
Jacksonville 2.265
San Jose 2.097
Singapore 2.097
Ashburn 2.051
Hong Kong 1.996
Nanjing 1.841
Dallas 1.651
Beijing 1.322
Boardman 987
Nanchang 757
Princeton 720
Lawrence 662
Lauterbourg 648
Wilmington 621
Ho Chi Minh City 608
Helsinki 593
Shenyang 553
Changsha 552
Los Angeles 549
Hebei 539
Medford 471
Munich 436
Jiaxing 426
Hanoi 414
New York 381
Hangzhou 319
Tianjin 308
Shanghai 285
Johannesburg 283
Redondo Beach 282
Moscow 280
Ann Arbor 276
Buffalo 257
Milan 225
São Paulo 172
Houston 152
Woodbridge 146
Turku 144
Pavia 142
Orem 135
Norwalk 132
Tokyo 129
Da Nang 119
Santa Clara 104
Seattle 101
Verona 100
Toronto 99
Chicago 95
Frankfurt am Main 95
Brooklyn 85
Fairfield 80
London 79
Warsaw 79
Council Bluffs 78
Falkenstein 78
Chennai 77
Montreal 77
Vienna 75
The Dalles 73
Guangzhou 70
Brussels 68
Rio de Janeiro 65
Haiphong 61
San Francisco 60
Zhengzhou 58
Atlanta 56
Denver 56
Jinan 56
Stockholm 56
Nuremberg 55
Baghdad 52
Washington 52
Boston 50
Pune 49
Manchester 48
Ningbo 48
Belo Horizonte 46
Tashkent 46
Amsterdam 45
Poplar 44
Columbus 43
Phoenix 42
Brasília 41
Mexico City 40
Ankara 39
Porto Alegre 39
Quito 37
Des Moines 35
Mumbai 34
Dhaka 33
Kunming 33
Biên Hòa 32
New Delhi 32
Piscataway 32
Jeddah 31
Lahore 31
Curitiba 30
Nairobi 30
Totale 38.421
Nome #
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 260
Ultrasonographic evaluation of entheses in patients with spondyloarthritis: a systematic literature review 192
Anterior chest wall arthritis and osteitis associated with Sneddon-Wilkinson disease 168
Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. 159
2-DE and LC-MS/MS for a Comparative Proteomic Analysis of BALf from Subjects with Different Subsets of Inflammatory Myopathies 152
-238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis. 151
[Italian Society of Rheumatology (SIR) recommendations for performing arthrocentesis.] 149
Assessment of synovitis to predict bone erosions in rheumatoid arthritis 149
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 146
Allopurinol Mouthwashes In Methotrexate-induced Stomatitis 145
B cells in rheumatoid arthritis. 145
Milwaukee shoulder syndrome(artropatia destruente apatite-associata):aspetti terapeutici 142
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 142
Anti-neutrophil cytoplasmic antibodies (ANCA) ( Review ) [Anticorpi anticitoplasma dei neutrofili (ANCA)] 138
B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers 138
Prevalence of undiagnosed autoimmune rheumatic diseases in the first trimester of pregnancy. Results of a two steps strategy using a self administered questionnaire and autoantibody testing. 138
Antinuclear antibodies in systemic sclerosis 137
Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study 137
In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: Comparison of two cohorts treated according to different treat to target protocols 135
A case of adult onset Still's disease treated with infliximab - Reply 135
[Health-related quality of life in patients with rheumatoid arthritis: assessment by a Italian version of the Arthritis Impact Measurement Scales, Version 2 (AIMS2)]. 134
Disease-related malnutrition in systemic sclerosis: Evidences and implications 134
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 134
Cardiovascular comorbidities relate more than others with disease activity in rheumatoid arthritis 133
DMARDS and infections in rheumatoid arthritis 132
Prognostic value of antisynthetase antibodies in patients affected by polymiositis/dermatomyositis with interstitial lung disease 132
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis 131
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 130
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 129
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 129
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 129
Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics 129
A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica. 128
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 128
Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. 127
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 127
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 126
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 125
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 125
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 125
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis 123
A Flow Cytometric Study of the Propidium Iodide Staining Kinetics of Human-leukocytes and Its Relationship With Chromatin Structure 123
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 123
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 123
20 years of experience with tumour necrosis factor inhibitors: what have we learned? 123
Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases 122
Multidisciplinary model for hospital-territory integrated management of patient with bone fragility: Primary and secondary prevention of fractures according to severity and complexity 122
Shrinking lung syndrome in sistemic sclerosis 122
Proliferation characteristics and polyploidization of cultured myofibroblasts from a patient with fibroblastic rheumatism 121
Microcytic anemia in rheumatoid arthritis. Relationship with activity and duration of the disease and iron status. 121
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 121
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 121
Clinical, genetic amd immunologic analysis of a family affected by Ozena. 120
Analysis of the apoliporotein(a) size polymorphism in patients with systemic lupus erythematosus 120
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 119
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. 118
B cells in rheumatoid arthritis. 118
[Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy]. 117
Antibodies to cyclic citrullinated peptides in psoriatic arthritis. 117
Analysis of Human Myeloma Cell-population Kinetics 117
Soluble HLA-G in pregnancies complicated by autoimmune rheumatic diseases 117
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs 117
Localized and systemic forms of scleroderma in adults and children. 116
Chemochine linfoidi nella sinovite reumatoide 116
Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study). 116
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 116
Impact of delayed diagnoses at the time of COVID-19: Increased rate of preventable bilateral blindness in giant cell arteritis 116
TNFalpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects. 115
Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital 115
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 115
The role of Trimethoprim/sulfametoxazole in reducing relapses and risk of infec-tions in ANCA-associated vasculitis: a meta-analysis 115
Interessamento cutaneo nella dermatomiosite 114
Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome. 114
Diffuse skin reaction after changing the etanercept formulation 114
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis 114
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 112
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 112
Mature antigen-experienced helper T cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of rheumatoid joint 112
Clinical, genetic and immunologic analysis of a family affected by ozena 111
Treatment of rheumatoid arthritis with anti-TNF-alpha agents: A reappraisal 111
A genetic variation located in the promoter region of the UPAR(CD87) gene is associated with the vascular complications of systemic sclerosis. 111
Influenza may influence rheumatoid arthritis 111
Lifestyle and dietary habits of patients with gout followed in rheumatology settings 111
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 111
Association between anti-dsDNA titre increase and thymoma relapse 110
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 110
B cell autoimmunity and bone damage in rheumatoid arthritis 110
Autoantibodies to heterogeneous nuclear ribonucleoproteins. 110
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management 110
A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome 109
Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis 109
G2 synchronization in human acute leukemia after VP 16 213 therapy. 109
Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series 109
Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. 109
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects]. 109
Impact of immunosuppressive treatment on the immunogenicity of mRNA Covid-19 vaccine in vulnerable patients with giant cell arteritis 109
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort 109
Clinical and experimental evidences of Italian viper venom neurotoxicity. 108
A Multicenter Retrospective Analysis Evaluating Performance of Synovial Biopsy Techniques in Patients With Inflammatory Arthritis: Arthroscopic Versus Ultrasound-Guided Versus Blind Needle Biopsy 108
Janus kinase inhibitors effectively improve pain across different disease activity states in rheumatoid arthritis 107
Totale 12.533
Categoria #
all - tutte 254.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 254.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.118 0 0 0 0 0 0 0 0 0 525 443 150
2021/20222.729 49 18 71 28 60 93 58 178 148 60 441 1.525
2022/20239.143 1.111 618 87 609 945 914 8 506 3.841 61 241 202
2023/20243.418 408 732 131 238 309 858 105 221 36 119 101 160
2024/20259.508 230 786 167 251 116 460 491 746 2.327 356 1.048 2.530
2025/202620.035 1.636 1.591 2.559 2.172 2.456 946 4.454 1.006 1.918 1.297 0 0
Totale 59.619